https://www.avient.com/sites/default/files/resources/Ramos%2520IATF%252016949-2016%2520exp%25207-10-2021_0.pdf
For and on behalf of BSI:
Carlos Pitanga, Chief Operating Officer Assurance – Americas
Certification Date: 2018-07-11 Latest Issue: 2018-07-11 Expiry Date: 2021-07-10
BSI Certificate Number: 85585
IATF Number: 0315491
Page: 1 of 2
This certificate remains the property of BSI and shall be returned immediately upon request.
Including the following remote support functions:
Polyone Corporation
33587 Walker Road
Avon Lake, OH 44012
USA
Audited by ABS Quality evaluations
Product Design, Purchasing, Customer Service and Strategic
Planning
Location Registered Activities
BSI Certificate Number: 85585
IATF Number: 0315491
Certification Date: 2018-07-11 Latest Issue: 2018-07-11 Expiry Date: 2021-07-10
Page: 2 of 2
This certificate remains the property of BSI and shall be returned immediately upon request.
https://www.avient.com/sites/default/files/2021-04/avient-sustain-2019-210419-interactive.pdf
Tianjin, China 2.
TRIR: 0.56
2.
PSIC: 0
2.
https://www.avient.com/sites/default/files/2020-10/2019-avient-sustainability-report.pdf
Tianjin, China 2.
TRIR: 0.56
2.
PSIC: 0
2.
https://www.avient.com/sites/default/files/2023-01/Carbon Footprint Infographic.pdf
company-owned vehicles, process emissions, and on-site heating) Scope 2: Indirect emissions from purchased indirect sources, such as the production of electricity and steam for an organization’s use Scope 3: Indirect emissions from sources up and down the supply chain, including materials, transportation of goods, and the processing, use, and end-of-life treatment of sold products Cradle-to-Gate: Carbon impact of a product from raw materials and product manufacturing Cradle-to-Grave: Carbon impact and analysis across the entire life cycle of a product from raw materials to disposal © 2023 Avient • www.avient.com • 1.844.4AVIENT Raw Materials Supply Chain UNDERSTANDING CARBON FOOTPRINT CO2e Transportation End-of-Life Treatment Processing of Goods Use of Products Transportation Chemical Processing Cradle-to-Gate (B2B) Cradle-to-Grave (B2C) SCOPE 3 INDIRECT SCOPE 3 INDIRECT Electricity Steam Company Facilities Company-Owned Vehicles SCOPE 1 DIRECT SCOPE 2 INDIRECT Reporting CompanyUpstream
https://www.avient.com/sites/default/files/2021-06/cartao-cnpj-avient-brasil-ltda.pdf
TÍTULO DO ESTABELECIMENTO (NOME DE FANTASIA)
********
PORTE
DEMAIS
CÓDIGO E DESCRIÇÃO DA ATIVIDADE ECONÔMICA PRINCIPAL
20.99-1-99 - Fabricação de outros produtos químicos não especificados anteriormente
CÓDIGO E DESCRIÇÃO DAS ATIVIDADES ECONÔMICAS SECUNDÁRIAS
46.79-6-01 - Comércio atacadista de tintas, vernizes e similares
46.84-2-99 - Comércio atacadista de outros produtos químicos e petroquímicos não especificados anteriormente
46.63-0-00 - Comércio atacadista de Máquinas e equipamentos para uso industrial; partes e peças
28.66-6-00 - Fabricação de máquinas e equipamentos para a indústria do plástico, peças e acessórios
82.11-3-00 - Serviços combinados de escritório e apoio administrativo
64.63-8-00 - Outras sociedades de participação, exceto holdings
71.20-1-00 - Testes e análises técnicas
22.29-3-02 - Fabricação de artefatos de material plástico para usos industriais
CÓDIGO E DESCRIÇÃO DA NATUREZA JURÍDICA
206-2 - Sociedade Empresária Limitada
LOGRADOURO
AV FRANCISCO NAKASATO
NÚMERO
1700
COMPLEMENTO
********
CEP
13.295-000
BAIRRO/DISTRITO
SAO ROQUE DA CHAVE
MUNICÍPIO
ITUPEVA
UF
SP
ENDEREÇO ELETRÔNICO
FABIANA.SILVA@POLYONE.COM
TELEFONE
(11) 4593-9279/ (11) 4593-9252
ENTE FEDERATIVO RESPONSÁVEL (EFR)
*****
SITUAÇÃO CADASTRAL
ATIVA
DATA DA SITUAÇÃO CADASTRAL
08/04/2005
MOTIVO DE SITUAÇÃO CADASTRAL
SITUAÇÃO ESPECIAL
********
DATA DA SITUAÇÃO ESPECIAL
********
Aprovado pela Instrução Normativa RFB nº 1.863, de 27 de dezembro de 2018.
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1)
AUTO-INJECTOR
APPLICATION STUDY
M A T E R I A L T E C H N O L O G I E S +
S E R V I C E S F O R N E X T
G E N E R A T I O N D E S I G N S
Avient Corporation 1
Avient Corporation 2
Innovating Design
Medical innovations and plastics have gone
hand-in-hand to make healthcare safer, cleaner,
and more accessible for all.
We can help tackle your toughest
challenges with our
• In-depth industry knowledge
• Expansive material solutions
• Far-reaching technical capabilities
and services
Avient Corporation 4
1
Injection window
Integrated rigid
needle shield
2
Cap
3
1.
Requirements:
Excellent clarity, scratch resistance
and exceptional toughness for
visualization of medicant
levels
Avient Distribution HC Portfolio:
Acrylic, copolyester, PC
2.
https://www.avient.com/sites/default/files/2021-01/w9-avient-corporation-july-2020.pdf
The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me); and
2.
You must cross out item 2 above if you have been notified by the IRS that you are currently subject to backup withholding because
you have failed to report all interest and dividends on your tax return.
For real estate transactions, item 2 does not apply.
https://www.avient.com/sites/default/files/2024-12/67599-Certificate-06DEC2024.pdf
Manufacture, Laboratory (QC and Colormatching), CSD Avenida Jorge Bei Maluf, 2.165 SP
Brazil
2 Lone Oak Court Toronto ON M9C
5A9 Canada
Avient (Chile) SpA Manufacture, Laboratory (QC and Colormatching), Sales Camino a Melipilla 15170 9250000
Maipú Chile
Avient Colombia S.A.S.
Central Office, Administration, Site management (Facitilities, EHS), Marketing and
Sales, SCM, Group Procurement Services, GBS and Logistics, GTI-Engineering and
R&D, Technical Application Laboratories, Legal, Finance, HR, IT, RSRA, SMD and
Learning, Communication
Bunkyo Green Court, 2-28-8, Tokyo
Tokyo 113-8662 Japan
Malaysia Sdn Bhd
Lot 1732, MK. 15, Kaw.
Development and manufacturing of Colorants products (including additive
Masterbatch)
No. 2 Nan Yun San Rd., Science City
510663 Guangzhou
(Shanghai) Ltd.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Goldman%2520Sachs%2520Conference%2520-%2520November%25202015.pdf
Slide 1
PolyOne Corporation Page 1
PolyOne Investor Presentation
Goldman Sachs 2015 US Emerging/
SMID Cap Growth Conference
November 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
Platform operating income mix percentage 2005* 2008* 2010* 2013 2014 2015 YTD
Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $104.0 $124.9 $ 107.9
Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 72.4 63.2
Designed Structures and Solutions - - - 33.4 45.1 12.0
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $194.6 $242.4 $ 183.1
Performance Products and Solutions 75.7 31.3 54.0 56.0 63.1 43.9
Distribution 19.5 28.1 42.0 63.3 68.2 52.4
Joint ventures 91.9 28.6 18.9 - - —
Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (218.6) (59.8)
Operating income (loss) GAAP $140.3 $(291.4) $174.6 $231.5 $155.1 $ 219.6
Less: Corporate operating expense 51.5 425.1 27.7 82.4 218.6 59.8
Operating income excluding Corporate $191.8 $133.7 $202.3 $313.9 $373.7 $ 279.4
Specialty platform operating mix percentage 2% 34% 43% 62% 65% 66%
Adjusted EPS is calculated as follows:
Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y
Net income attributable to
PolyOne common
shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0
Joint venture equity earnings,
after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - -
Special items, after tax(1) (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 101.0
Tax adjustments(2) (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (10.5)
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80
2
Adjusted EPS 2011 Q3 2012 Q3 2013 Q3 2014 Q3 2015 Q3
Net income attributable to PolyOne common shareholders $ 16.0 $ 19.4 $ 23.2 $ 32.3 $ 44.5
Special items, after tax(1) 3.1 5.3 10.5 13.2 12.6
Tax adjustments(2) (0.3) 0.1 1.8 (0.1) (9.6)
Adjusted net income $ 18.8 $ 24.8 $ 35.5 $ 45.4 $ 47.5
Diluted shares 94.3 90.2 98.1 93.1 88.4
Adjusted EPS $ 0.20 $ 0.27 $ 0.36 $ 0.49 $ 0.54
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations
2) Tax adjustments include the net tax expense/benefit from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuations allowance adjustments.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Jefferies%2520Industrials%2520Conference%25202015.pdf
PolyOne Corporation Page 1
PolyOne Investor Presentation
Jefferies 2015 Industrials Conference
August 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
S&P 500
PolyOne Corporation Page 9
2006 YTD 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 17.2% 20%+
Global Specialty Engineered
Materials 1.1% 15.3% 20%+
Designed Structures & Solutions 1.4% (2012) 3.3% 12 – 14%
Performance Products &
Solutions 5.5% 7.6% 10 – 12%
Distribution 2.6% 6.5% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 67% 80%+
3) ROIC (after-tax)* 5.0% 11.7% 15%
4) Adjusted EPS Growth N/A
23 Consecutive
Quarters of YOY
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
*ROIC is defined as TTM adjusted operating income after-tax divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions) $700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
102%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q2 2015
Pension Funding**
As of June 30, 2015
Debt Maturities & Pension Funding
Net Debt / Adjusted EBITDA** = 2.0x
Coupon Rate: 7.500% Variable* 7.375% 5.250%
** includes US-qualified pension plans only *Weighted average rate on revolver was 2.40% as of 6/30/15 **TTM 6/30/2015
$49
$79
$317
$600
$400
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2018 2020 2023
Debt Maturities
As of June 30, 2015
($ millions)
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased nearly
600K shares in Q2
2015
Repurchased 12.4
million shares since
early 2013
7.6 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y
Net income attributable to
PolyOne common
shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0
Joint venture equity earnings,
after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - -
Special items, after tax(1) (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 101.0
Tax adjustments(2) (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (10.5)
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80
Adjusted EPS 2010 Q2 2011 Q2 2012 Q2 2013 Q2 2014 Q2 2015 Q2
Net income attributable to PolyOne common shareholders $ 44.7 $ 23.1 $ 18.4 $ 38.6 $ 30.9 $ 66.8
Joint venture equity earnings, after tax (4.5) - - - - -
Special items, after tax(1) (9.0) 0.9 8.0 (2.2) 22.6 8.0
Tax adjustments(2) (13.1) 0.4 0.9 0.2 (5.2) (23.9)
Adjusted net income $ 18.1 $ 24.4 $ 27.3 $ 36.6 $ 48.3 $ 50.9
Diluted shares 96.3 95.5 90.7 99.1 94.3 89.8
Adjusted EPS $ 0.19 $ 0.26 $ 0.30 $ 0.37 $ 0.51 $ 0.57
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations